Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Melek Karadag-Assem

Research Assistant (NTAD)

Melek works on the DPUK-funded New Therapeutics in Alzheimer's Disease (NTAD) research study, which aims to identify early biomarkers for Alzheimer's disease using MEG and EEG brain imaging techniques. She is based at the Cambridge Centre for Frontotemporal Dementia and Related Disorders at the University of Cambridge.

Prior to working at Cambridge, Melek completed a master's degree at the Basque Center On Cognition, Brain and Language.